Targeted Radionuclide Therapy

Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients

(2010) Andrew S. Kennedy et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

131I-Metaiodobenzylguanidine Therapy of Neuroblastoma and Other Neuroendocrine Tumors

(2010) Frank Grünwald et al.   SEMINARS IN NUCLEAR MEDICINE

Update on Recent Developments in the Therapy of Differentiated Thyroid Cancer

(2010) Marcus Middendorp et al.   SEMINARS IN NUCLEAR MEDICINE

Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain

(2010) Fabio M. Paes et al.   SEMINARS IN NUCLEAR MEDICINE

Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres

(2009) Mary F. Mulcahy et al.   CANCER

Selective Internal Radiotherapy with Yttrium-90 Microspheres for Hepatic Metastatic Neuroendocrine Tumors: A Prospective Single Center Study

(2009) Marc Kalinowski et al.   DIGESTION

Implications of the molecular characterization of the sodium-iodide symporter (NIS)

(2009) C. Schmutzler et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

(2009) Dik J. Kwekkeboom et al.   NEUROENDOCRINOLOGY

Assessment of Metabolic Response to Radioimmunotherapy with90Y–Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non–Hodgkin Lymphoma

(2009) Giovanni Storto et al.   RADIOLOGY

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres

(2008) Saad M. Ibrahim et al.   CANCER

Guidelines for radioiodine therapy of differentiated thyroid cancer

(2008) M. Luster et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy

(2008) Michael Lassmann et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

(2008) Franck Morschhauser et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Myeloablative 131I-Tositumomab Radioimmunotherapy in Treating Non-Hodgkin's Lymphoma: Comparison of Dosimetry Based on Whole-Body Retention and Dose to Critical Organ Receiving the Highest Dose

(2008) J. G. Rajendran et al.   JOURNAL OF NUCLEAR MEDICINE